University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
1004 Ergebnisse für "later" unter University of Zurich
Early Onset of Improvement Predicts Later Response
... Later Response Incidence and Latency The two central aspects of psychotropic drug response, the ... small. ⇒ Meeting improvement criteria is highly predictive of later outcome, as typically ... Early Onset of Improvement Predicts Later Response ... Early Onset of Improvement Predicts Later Response Research Group 'Psychiatric Genetics', Head ... Early Onset of Improvement Predicts Later Response ...
Introductory Remarks: Competing Notions of Order in the Later Ottom...
... Notions of Order in the Later Ottoman Empire (18th–20th Centuries). Welt des Islams (Die), 54(3–4):287-291 ... Introductory Remarks: Competing Notions of Order in the Later Ottoman Empire (18th–20th Centuries) - ... Introductory Remarks: Competing Notions of Order in the Later Ottoman Empire (18th–20th Centuries ... Introductory Remarks: Competing Notions of Order in the Later Ottoman Empire (18th–20th Centuries) - ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1498 Ergebnisse für "later" unter ETH Entrepreneurship
Russian Analytical Digest No 127: Putin 3.0: One Year Later - Exper...
... Russian Analytical Digest No 127: Putin 3.0: One Year Later - Expert Perspectives No. 127 ... analytical digest 8 May 2013 PUTIN 3.0: ONE YEAR LATER—EXPERT PERSPECTIVES russian www.css.ethz.ch/rad ... Russian Analytical Digest No 127: Putin 3.0: One Year Later - Expert Perspectives ... Russian Analytical Digest No 127: Putin 3.0: One Year Later - Expert Perspectives No. 127 ... Russian Analytical Digest No 127: Putin 3.0: One Year Later - Expert Perspectives ...
Video Shooting with Benjamin Huggel – Sensory-Motor Systems Lab | E...
... April 11, we did the movie recordings in a green box. This content will later be used for the training ... Palindrom call_made . On April 11, we did the movie recordings in a green box. This content will later be ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
1627 Ergebnisse für "later" unter Somagenetix
Ad fontes: Tutorial / German Language in the Sources / Later Lingui...
... Ad fontes: Tutorial / German Language in the Sources / Later Linguistic Changes ... Ad fontes: Tutorial / German Language in the Sources / Later Linguistic Changes All pages All pages ... Ad fontes: Tutorial / German Language in the Sources / Later Linguistic Changes ...
Mechanisms linking preterm birth to onset of cardiovascular disease...
... to primary and secondary prevention of CVD and improve survival among preterm neonates later in adult ... to primary and secondary prevention of CVD and improve survival among preterm neonates later in adult ... Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood - Zurich ... Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood - Zurich ... Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood - Zurich ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
114 Ergebnisse für "later" unter University Hospital Zurich, Research and Education Office
... , BrainDNIU study (Impact of intrauterine growth restriction on brain development and consequences for later ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
528 Ergebnisse für "later" unter Roche Glycart AG
cobas c 502 module
... och visa webbplatsen i icke-privat surfningsläge. cobas c 502 module Please try again later ©2022 ...
cobas e 602 module
... och visa webbplatsen i icke-privat surfningsläge. cobas e 602 module Please try again later ©2022 ...
Standortförderung Kanton Zürich
https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html
8090 Zürich, Walchestrasse 19
+41 43 259 49 92
standort@vd.zh.ch
The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.
Standortförderung Kanton Zürich
Walchestrasse 19
8090 Zürich
21 Ergebnisse für "later" unter Standortförderung Kanton Zürich
Prüfberichte Ausführungskontrolle Betrieblicher Umweltschutz
... document, you need a later version of the PDF viewer. You can upgrade to the latest version of Adobe Reader ... document, you need a later version of the PDF viewer. You can upgrade to the latest version of Adobe Reader ...
Prüfberichte Projektkontrolle Betrieblicher Umweltschutz
... , you need a later version of the PDF viewer. You can upgrade to the latest version of Adobe Reader from ... , you need a later version of the PDF viewer. You can upgrade to the latest version of Adobe Reader from ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
13 Ergebnisse für "later" unter CSL Vifor
CSL Annual Report 2022 – Page 129
... financial statements are payable as follows: Capital Commitments 2022 US$m 2021 US$m Not later than one year ... 403.2 520.0 Later than one year but not later than five years 83.3 24.3 Total 486.5 544.3 The Company ... US$m 2021 US$m Not later than one year 403.2 520.0 Later than one year but not later than five years ...
CSL Annual Report 2023 – Page 149
... financial statements are payable as follows: Capital Commitments 2023 US$m 2022 US$m Not later than one year ... 411 403 Later than one year but not later than five years 84 83 Total 495 486 (b) Contingent assets ... US$m 2022 US$m Not later than one year 411 403 Later than one year but not later than five years 84 ...
SecureCell AG
8902 Urdorf, In der Luberzen 29
+41 44 732 91 00
contact@securecell.ch
Securecell is pioneering the world’s next solutions for global biotech and MedTech systems. From automated bioprocessing and smart pharmacological facilities to the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems. At Securecell we believe the best future should be our next future, hence our technologies represent innovative solutions that can improve lives on a global scale.
SecureCell AG
In der Luberzen 29
8902 Urdorf
4 Ergebnisse für "later" unter SecureCell AG
Securecell | Modular Sampling System – Sample Collector
... in order to analyze them later, e.g. if the analyzer is not directly on-site. Some cases require both ... analyze them later, e.g. if the analyzer is not directly on-site. Some cases require both analytics and ...
Securecell | Modular Sampling System - Dilution Module
... allows the later detection of the product. The dilution module – which can be used either before the ... with the analysis, the product has to be extracted from the cell, or a dyeing reaction allows the later ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
12 Ergebnisse für "later" unter Bio-Technopark Schlieren-Zürich
Schlieren BBQ sponsored by LubioScience › BIO-TECHNOPARK® Schlieren...
... ? Register here no later than June 30. Registration is mandatory so that we can plan the quantities. We look ... event in Schlieren and meet the Lubio team! Ready for the party? Register here no later than June 30 ...
Schlieren BBQ sponsored by LubioScience › BIO-TECHNOPARK® Schlieren...
... ? Register here no later than June 30. Registration is mandatory so that we can plan the quantities. We look ... later than June 30. Registration is mandatory so that we can plan the quantities. We look forward to ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
13 Ergebnisse für "later" unter Neurimmune Therapeutics AG
Neurimmune Holding AG | Technology platform
... antibody responses, Neurimmune identifies genes of antibody candidates which later on need to prove their ... being based on antibody responses, Neurimmune identifies genes of antibody candidates which later on ...
Neurimmune Holding AG | Strategy
... of antibody candidates which later on need to prove their efficiency in vitro or in vivo model ... , Neurimmune identifies genes of antibody candidates which later on need to prove their efficiency in vitro or ...
